Sambrinvest
Overview
Sambrinvest is a venture capital firm based in the Walloon Region (Charleroi Metropole), Belgium. With over 40 years of experience, they invest in SMEs and startups, particularly in the Charleroi and Thuin regions. They focus on sectors including industry, agrifood, materials, and life sciences. Sambrinvest provides financial solutions tailored to the needs of SMEs, offering capital participation, and support for the economic and social development of the Charleroi area.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Enky | Sep 2020 | Seed | Co-investor |
| Serendipia Life | Sep 2020 | Convertible Debt | Co-investor |
| 2houses | Feb 2019 | Debt | Co-investor |
| AbolerIS Pharma | Sep 2023 | Series A | Co-investor |
| Bioxodes | Dec 2025 | Series B | Co-investor |
For institutional investors. Book with your work email.
Key People
Elisabeth de Halleux
Investment Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Sambrinvest based?
Sambrinvest is headquartered in Hainaut.
When was Sambrinvest founded?
Sambrinvest was founded in 1985.
How many portfolio companies does Sambrinvest have?
Sambrinvest has 48 portfolio companies in Caplight's dataset.
What are some companies in Sambrinvest's portfolio?
Portfolio companies visible on Caplight include Enky, Serendipia Life, 2houses, AbolerIS Pharma, Bioxodes.
What was Sambrinvest's most recent investment shown here?
Sambrinvest's most recent investment in this portfolio sample was in Bioxodes in 2025.
What sectors does Sambrinvest focus on?
Sambrinvest focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Consumer & Commerce, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, Mobility, Transportation & Logistics, Real Estate & PropTech, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Real Estate & PropTech, AI, Data & Cloud Infrastructure, Real Estate & PropTech, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Consumer & Commerce, Cybersecurity, Enterprise Software, Enterprise Software, Mobility, Transportation & Logistics, Frontier & Industrial Tech, Real Estate & PropTech, AI, Data & Cloud Infrastructure, FinTech, AI, Data & Cloud Infrastructure, Energy & Sustainability, Consumer & Commerce, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Consumer & Commerce, Consumer & Commerce, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, FinTech, Telecommunications & Networking, Enterprise Software, Enterprise Software, Energy & Sustainability.
What company stages does Sambrinvest focus on?
Sambrinvest typically invests at the Early stage.
What is Sambrinvest's AUM?
Sambrinvest's assets under management are estimated between $100.0M and $250.0M.